Header Logo

Connection

OLIVE ECKSTEIN to Etanercept

Back to Details
This is a "connection" page, showing publications OLIVE ECKSTEIN has written about Etanercept.
OLIVE ECKSTEIN
Connection Strength
0.157
Etanercept
  1. Anti TNF-a therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study. Pediatr Hematol Oncol. 2018 Aug - Sep; 35(5-6):362-368.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.